[1]
“Biomanufacturing and Scale-Up of Clinical-Grade Induced Pluripotent Stem Cell Lines”, ASCR, vol. 8, no. 1, pp. 51–58, Sep. 2025, doi: 10.5281/zenodo.22274707.